{
  "ticker": "ABBV",
  "last_updated": "2025-04-15T14:53:27.739286",
  "retention_years": 3,
  "count": 154,
  "transactions": [
    {
      "id": 111658,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-05-11",
      "transaction_shares": "2876",
      "transaction_price": "146.42",
      "transaction_type": "F",
      "shares_after_transaction": "28024"
    },
    {
      "id": 111633,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RAPP EDWARD J",
      "reporting_owner_cik": "0001171780",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-05",
      "transaction_shares": "1450",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30034"
    },
    {
      "id": 111635,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "BURNSIDE WILLIAM H.L.",
      "reporting_owner_cik": "0001563579",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-05",
      "transaction_shares": "1450",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24433"
    },
    {
      "id": 111639,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "FREYMAN THOMAS C",
      "reporting_owner_cik": "0001239126",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-05",
      "transaction_shares": "1450",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "124226"
    },
    {
      "id": 111661,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "MEYER MELODY B",
      "reporting_owner_cik": "0001706126",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-05",
      "transaction_shares": "1450",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13973"
    },
    {
      "id": 111662,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "TILTON GLENN F",
      "reporting_owner_cik": "0001194624",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-05",
      "transaction_shares": "1450",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49039"
    },
    {
      "id": 111667,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Alpern Robert J",
      "reporting_owner_cik": "0001448074",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-05",
      "transaction_shares": "1450",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "32992"
    },
    {
      "id": 111669,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "WADDELL FREDERICK H",
      "reporting_owner_cik": "0001223690",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-05",
      "transaction_shares": "1450",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26433"
    },
    {
      "id": 111682,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hart Brett J",
      "reporting_owner_cik": "0001466338",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-05",
      "transaction_shares": "1450",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16947"
    },
    {
      "id": 111684,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Roberts Rebecca B",
      "reporting_owner_cik": "0001355580",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-05",
      "transaction_shares": "1450",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11203"
    },
    {
      "id": 111699,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "AUSTIN ROXANNE S",
      "reporting_owner_cik": "0001061632",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-05",
      "transaction_shares": "1450",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35933"
    },
    {
      "id": 111674,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-04-25",
      "transaction_shares": "6130",
      "transaction_price": "144.54",
      "transaction_type": "M",
      "shares_after_transaction": "41460"
    },
    {
      "id": 111630,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-04-17",
      "transaction_shares": "6999",
      "transaction_price": "161.64",
      "transaction_type": "S",
      "shares_after_transaction": "35830"
    },
    {
      "id": 71084,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-04-03",
      "transaction_shares": "3520",
      "transaction_price": "105.92",
      "transaction_type": "M",
      "shares_after_transaction": "13897"
    },
    {
      "id": 71100,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-04-03",
      "transaction_shares": "15002",
      "transaction_price": "93.50",
      "transaction_type": "M",
      "shares_after_transaction": "57831"
    },
    {
      "id": 111659,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-04-03",
      "transaction_shares": "3520",
      "transaction_price": "105.92",
      "transaction_type": "M",
      "shares_after_transaction": "13897"
    },
    {
      "id": 111683,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-04-03",
      "transaction_shares": "15002",
      "transaction_price": "93.50",
      "transaction_type": "M",
      "shares_after_transaction": "57831"
    },
    {
      "id": 71094,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2023-03-13",
      "transaction_shares": "21810",
      "transaction_price": "54.86",
      "transaction_type": "M",
      "shares_after_transaction": "114066"
    },
    {
      "id": 111675,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2023-03-13",
      "transaction_shares": "21810",
      "transaction_price": "54.86",
      "transaction_type": "M",
      "shares_after_transaction": "114066"
    },
    {
      "id": 71114,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-03-05",
      "transaction_shares": "449",
      "transaction_price": "156.06",
      "transaction_type": "F",
      "shares_after_transaction": "30900"
    },
    {
      "id": 111698,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-03-05",
      "transaction_shares": "449",
      "transaction_price": "156.06",
      "transaction_type": "F",
      "shares_after_transaction": "30900"
    },
    {
      "id": 71067,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-03-03",
      "transaction_shares": "2550",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "643794"
    },
    {
      "id": 111640,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-03-03",
      "transaction_shares": "2550",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "643794"
    },
    {
      "id": 71062,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-02-28",
      "transaction_shares": "5762",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "32159"
    },
    {
      "id": 71070,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, R&D AND CSO",
      "transaction_date": "2023-02-28",
      "transaction_shares": "27922",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "81329"
    },
    {
      "id": 71073,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "VICE CHAIRMAN",
      "transaction_date": "2023-02-28",
      "transaction_shares": "48335",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "98645"
    },
    {
      "id": 71077,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "35111",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "57978"
    },
    {
      "id": 71078,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "19850",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "42829"
    },
    {
      "id": 71085,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "33359",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "199849"
    },
    {
      "id": 71086,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "24910",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "92256"
    },
    {
      "id": 71089,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "12683",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "16751"
    },
    {
      "id": 71091,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Durkin Brian L",
      "reporting_owner_cik": "0001756865",
      "reporting_owner_position": "VP, CONTROLLER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "11182",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "33149"
    },
    {
      "id": 71109,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-28",
      "transaction_shares": "9656",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "22512"
    },
    {
      "id": 71110,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-02-28",
      "transaction_shares": "113810",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "646344"
    },
    {
      "id": 111632,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-02-28",
      "transaction_shares": "5762",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "32159"
    },
    {
      "id": 111643,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, R&D AND CSO",
      "transaction_date": "2023-02-28",
      "transaction_shares": "27922",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "81329"
    },
    {
      "id": 111646,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "VICE CHAIRMAN",
      "transaction_date": "2023-02-28",
      "transaction_shares": "48335",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "98645"
    },
    {
      "id": 111651,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "35111",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "57978"
    },
    {
      "id": 111652,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "19850",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "42829"
    },
    {
      "id": 111660,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "33359",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "199849"
    },
    {
      "id": 111663,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "24910",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "92256"
    },
    {
      "id": 111666,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "12683",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "16751"
    },
    {
      "id": 111671,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Durkin Brian L",
      "reporting_owner_cik": "0001756865",
      "reporting_owner_position": "VP, CONTROLLER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "11182",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "33149"
    },
    {
      "id": 111693,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-28",
      "transaction_shares": "9656",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "22512"
    },
    {
      "id": 111694,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-02-28",
      "transaction_shares": "113810",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "646344"
    },
    {
      "id": 71068,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-21",
      "transaction_shares": "7364",
      "transaction_price": "93.50",
      "transaction_type": "M",
      "shares_after_transaction": "39532"
    },
    {
      "id": 111641,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-21",
      "transaction_shares": "7364",
      "transaction_price": "93.50",
      "transaction_type": "M",
      "shares_after_transaction": "39532"
    },
    {
      "id": 71090,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "AUSTIN ROXANNE S",
      "reporting_owner_cik": "0001061632",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-17",
      "transaction_shares": "10000",
      "transaction_price": "150.50",
      "transaction_type": "S",
      "shares_after_transaction": "40705"
    },
    {
      "id": 111668,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "AUSTIN ROXANNE S",
      "reporting_owner_cik": "0001061632",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-17",
      "transaction_shares": "10000",
      "transaction_price": "150.50",
      "transaction_type": "S",
      "shares_after_transaction": "40705"
    },
    {
      "id": 71065,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "18715",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19524"
    },
    {
      "id": 71066,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, R&D AND CSO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "40640",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "86868"
    },
    {
      "id": 71075,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Durkin Brian L",
      "reporting_owner_cik": "0001756865",
      "reporting_owner_position": "VP, CONTROLLER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "16042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35136"
    },
    {
      "id": 71080,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "29410",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47286"
    },
    {
      "id": 71083,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "32085",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93026"
    },
    {
      "id": 71088,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "VICE CHAIRMAN",
      "transaction_date": "2023-02-16",
      "transaction_shares": "69517",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "107394"
    },
    {
      "id": 71095,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "51335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65172"
    },
    {
      "id": 71096,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "6546",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47209"
    },
    {
      "id": 71101,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-16",
      "transaction_shares": "14437",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24814"
    },
    {
      "id": 71103,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "149732",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "652985"
    },
    {
      "id": 71104,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "48127",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "206039"
    },
    {
      "id": 111637,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "18715",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19524"
    },
    {
      "id": 111638,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, R&D AND CSO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "40640",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "86868"
    },
    {
      "id": 111648,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Durkin Brian L",
      "reporting_owner_cik": "0001756865",
      "reporting_owner_position": "VP, CONTROLLER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "16042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35136"
    },
    {
      "id": 111654,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "29410",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47286"
    },
    {
      "id": 111657,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "32085",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93026"
    },
    {
      "id": 111665,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "VICE CHAIRMAN",
      "transaction_date": "2023-02-16",
      "transaction_shares": "69517",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "107394"
    },
    {
      "id": 111676,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "51335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65172"
    },
    {
      "id": 111677,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "6546",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47209"
    },
    {
      "id": 111685,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-16",
      "transaction_shares": "14437",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24814"
    },
    {
      "id": 111687,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "149732",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "652985"
    },
    {
      "id": 111688,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "48127",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "206039"
    },
    {
      "id": 39462,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2022-12-12",
      "transaction_shares": "42370",
      "transaction_price": "54.86",
      "transaction_type": "M",
      "shares_after_transaction": "56207"
    },
    {
      "id": 71107,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2022-12-12",
      "transaction_shares": "42370",
      "transaction_price": "54.86",
      "transaction_type": "M",
      "shares_after_transaction": "56207"
    },
    {
      "id": 111691,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2022-12-12",
      "transaction_shares": "42370",
      "transaction_price": "54.86",
      "transaction_type": "M",
      "shares_after_transaction": "56207"
    },
    {
      "id": 6820,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-23",
      "transaction_shares": "46320",
      "transaction_price": "114.36",
      "transaction_type": "M",
      "shares_after_transaction": "198423"
    },
    {
      "id": 19763,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-23",
      "transaction_shares": "46320",
      "transaction_price": "114.36",
      "transaction_type": "M",
      "shares_after_transaction": "198423"
    },
    {
      "id": 39447,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-23",
      "transaction_shares": "46320",
      "transaction_price": "114.36",
      "transaction_type": "M",
      "shares_after_transaction": "198423"
    },
    {
      "id": 71071,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-23",
      "transaction_shares": "46320",
      "transaction_price": "114.36",
      "transaction_type": "M",
      "shares_after_transaction": "198423"
    },
    {
      "id": 111644,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-23",
      "transaction_shares": "46320",
      "transaction_price": "114.36",
      "transaction_type": "M",
      "shares_after_transaction": "198423"
    },
    {
      "id": 6818,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Gosebruch Henry O",
      "reporting_owner_cik": "0001659625",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2022-05-16",
      "transaction_shares": "83960",
      "transaction_price": "54.86",
      "transaction_type": "M",
      "shares_after_transaction": "100583"
    },
    {
      "id": 6824,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-16",
      "transaction_shares": "70879",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "222982"
    },
    {
      "id": 19761,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Gosebruch Henry O",
      "reporting_owner_cik": "0001659625",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2022-05-16",
      "transaction_shares": "83960",
      "transaction_price": "54.86",
      "transaction_type": "M",
      "shares_after_transaction": "100583"
    },
    {
      "id": 19768,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-16",
      "transaction_shares": "70879",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "222982"
    },
    {
      "id": 39445,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Gosebruch Henry O",
      "reporting_owner_cik": "0001659625",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2022-05-16",
      "transaction_shares": "83960",
      "transaction_price": "54.86",
      "transaction_type": "M",
      "shares_after_transaction": "100583"
    },
    {
      "id": 39454,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-16",
      "transaction_shares": "70879",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "222982"
    },
    {
      "id": 71064,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Gosebruch Henry O",
      "reporting_owner_cik": "0001659625",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2022-05-16",
      "transaction_shares": "83960",
      "transaction_price": "54.86",
      "transaction_type": "M",
      "shares_after_transaction": "100583"
    },
    {
      "id": 71087,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-16",
      "transaction_shares": "70879",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "222982"
    },
    {
      "id": 111636,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Gosebruch Henry O",
      "reporting_owner_cik": "0001659625",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2022-05-16",
      "transaction_shares": "83960",
      "transaction_price": "54.86",
      "transaction_type": "M",
      "shares_after_transaction": "100583"
    },
    {
      "id": 111664,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-16",
      "transaction_shares": "70879",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "222982"
    },
    {
      "id": 6825,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & Pres Global Allerg Aesth",
      "transaction_date": "2022-05-11",
      "transaction_shares": "2876",
      "transaction_price": "152.09",
      "transaction_type": "F",
      "shares_after_transaction": "40663"
    },
    {
      "id": 19769,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & Pres Global Allerg Aesth",
      "transaction_date": "2022-05-11",
      "transaction_shares": "2876",
      "transaction_price": "152.09",
      "transaction_type": "F",
      "shares_after_transaction": "40663"
    },
    {
      "id": 39455,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & Pres Global Allerg Aesth",
      "transaction_date": "2022-05-11",
      "transaction_shares": "2876",
      "transaction_price": "152.09",
      "transaction_type": "F",
      "shares_after_transaction": "40663"
    },
    {
      "id": 71092,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & Pres Global Allerg Aesth",
      "transaction_date": "2022-05-11",
      "transaction_shares": "2876",
      "transaction_price": "152.09",
      "transaction_type": "F",
      "shares_after_transaction": "40663"
    },
    {
      "id": 111672,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & Pres Global Allerg Aesth",
      "transaction_date": "2022-05-11",
      "transaction_shares": "2876",
      "transaction_price": "152.09",
      "transaction_type": "F",
      "shares_after_transaction": "40663"
    },
    {
      "id": 6817,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & Pres Global Allerg Aesth",
      "transaction_date": "2022-05-07",
      "transaction_shares": "234",
      "transaction_price": "152.83",
      "transaction_type": "F",
      "shares_after_transaction": "43539"
    },
    {
      "id": 19760,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & Pres Global Allerg Aesth",
      "transaction_date": "2022-05-07",
      "transaction_shares": "234",
      "transaction_price": "152.83",
      "transaction_type": "F",
      "shares_after_transaction": "43539"
    },
    {
      "id": 39444,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & Pres Global Allerg Aesth",
      "transaction_date": "2022-05-07",
      "transaction_shares": "234",
      "transaction_price": "152.83",
      "transaction_type": "F",
      "shares_after_transaction": "43539"
    },
    {
      "id": 71063,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & Pres Global Allerg Aesth",
      "transaction_date": "2022-05-07",
      "transaction_shares": "234",
      "transaction_price": "152.83",
      "transaction_type": "F",
      "shares_after_transaction": "43539"
    },
    {
      "id": 111634,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & Pres Global Allerg Aesth",
      "transaction_date": "2022-05-07",
      "transaction_shares": "234",
      "transaction_price": "152.83",
      "transaction_type": "F",
      "shares_after_transaction": "43539"
    },
    {
      "id": 6816,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Alpern Robert J",
      "reporting_owner_cik": "0001448074",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "31542"
    },
    {
      "id": 6819,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "FREYMAN THOMAS C",
      "reporting_owner_cik": "0001239126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "122776"
    },
    {
      "id": 6821,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "MEYER MELODY B",
      "reporting_owner_cik": "0001706126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12523"
    },
    {
      "id": 6822,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RAPP EDWARD J",
      "reporting_owner_cik": "0001171780",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "28584"
    },
    {
      "id": 6823,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "TILTON GLENN F",
      "reporting_owner_cik": "0001194624",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47589"
    },
    {
      "id": 6826,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hart Brett J",
      "reporting_owner_cik": "0001466338",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "15497"
    },
    {
      "id": 6827,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Roberts Rebecca B",
      "reporting_owner_cik": "0001355580",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9753"
    },
    {
      "id": 6830,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-06",
      "transaction_shares": "74309",
      "transaction_price": "54.44",
      "transaction_type": "M",
      "shares_after_transaction": "226412"
    },
    {
      "id": 6831,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "BURNSIDE WILLIAM H.L.",
      "reporting_owner_cik": "0001563579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "22983"
    },
    {
      "id": 6832,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "AUSTIN ROXANNE S",
      "reporting_owner_cik": "0001061632",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50705"
    },
    {
      "id": 6833,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "WADDELL FREDERICK H",
      "reporting_owner_cik": "0001223690",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24983"
    },
    {
      "id": 19759,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Alpern Robert J",
      "reporting_owner_cik": "0001448074",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "31542"
    },
    {
      "id": 19762,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "FREYMAN THOMAS C",
      "reporting_owner_cik": "0001239126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "122776"
    },
    {
      "id": 19764,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "MEYER MELODY B",
      "reporting_owner_cik": "0001706126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12523"
    },
    {
      "id": 19765,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RAPP EDWARD J",
      "reporting_owner_cik": "0001171780",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "28584"
    },
    {
      "id": 19766,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "TILTON GLENN F",
      "reporting_owner_cik": "0001194624",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47589"
    },
    {
      "id": 19770,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hart Brett J",
      "reporting_owner_cik": "0001466338",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "15497"
    },
    {
      "id": 19771,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Roberts Rebecca B",
      "reporting_owner_cik": "0001355580",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9753"
    },
    {
      "id": 19774,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-06",
      "transaction_shares": "74309",
      "transaction_price": "54.44",
      "transaction_type": "M",
      "shares_after_transaction": "226412"
    },
    {
      "id": 19775,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "BURNSIDE WILLIAM H.L.",
      "reporting_owner_cik": "0001563579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "22983"
    },
    {
      "id": 19776,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "AUSTIN ROXANNE S",
      "reporting_owner_cik": "0001061632",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50705"
    },
    {
      "id": 19778,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "WADDELL FREDERICK H",
      "reporting_owner_cik": "0001223690",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24983"
    },
    {
      "id": 39443,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Alpern Robert J",
      "reporting_owner_cik": "0001448074",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "31542"
    },
    {
      "id": 39446,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "FREYMAN THOMAS C",
      "reporting_owner_cik": "0001239126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "122776"
    },
    {
      "id": 39448,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "MEYER MELODY B",
      "reporting_owner_cik": "0001706126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12523"
    },
    {
      "id": 39449,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RAPP EDWARD J",
      "reporting_owner_cik": "0001171780",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "28584"
    },
    {
      "id": 39451,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "TILTON GLENN F",
      "reporting_owner_cik": "0001194624",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47589"
    },
    {
      "id": 39456,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hart Brett J",
      "reporting_owner_cik": "0001466338",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "15497"
    },
    {
      "id": 39457,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Roberts Rebecca B",
      "reporting_owner_cik": "0001355580",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9753"
    },
    {
      "id": 39460,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-06",
      "transaction_shares": "74309",
      "transaction_price": "54.44",
      "transaction_type": "M",
      "shares_after_transaction": "226412"
    },
    {
      "id": 39461,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "BURNSIDE WILLIAM H.L.",
      "reporting_owner_cik": "0001563579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "22983"
    },
    {
      "id": 39463,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "AUSTIN ROXANNE S",
      "reporting_owner_cik": "0001061632",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50705"
    },
    {
      "id": 39465,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "WADDELL FREDERICK H",
      "reporting_owner_cik": "0001223690",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24983"
    },
    {
      "id": 71061,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Alpern Robert J",
      "reporting_owner_cik": "0001448074",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "31542"
    },
    {
      "id": 71069,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "FREYMAN THOMAS C",
      "reporting_owner_cik": "0001239126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "122776"
    },
    {
      "id": 71072,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "MEYER MELODY B",
      "reporting_owner_cik": "0001706126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12523"
    },
    {
      "id": 71074,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RAPP EDWARD J",
      "reporting_owner_cik": "0001171780",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "28584"
    },
    {
      "id": 71079,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "TILTON GLENN F",
      "reporting_owner_cik": "0001194624",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47589"
    },
    {
      "id": 71093,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hart Brett J",
      "reporting_owner_cik": "0001466338",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "15497"
    },
    {
      "id": 71098,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Roberts Rebecca B",
      "reporting_owner_cik": "0001355580",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9753"
    },
    {
      "id": 71105,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-06",
      "transaction_shares": "74309",
      "transaction_price": "54.44",
      "transaction_type": "M",
      "shares_after_transaction": "226412"
    },
    {
      "id": 71106,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "BURNSIDE WILLIAM H.L.",
      "reporting_owner_cik": "0001563579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "22983"
    },
    {
      "id": 71108,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "AUSTIN ROXANNE S",
      "reporting_owner_cik": "0001061632",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50705"
    },
    {
      "id": 71113,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "WADDELL FREDERICK H",
      "reporting_owner_cik": "0001223690",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24983"
    },
    {
      "id": 111631,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Alpern Robert J",
      "reporting_owner_cik": "0001448074",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "31542"
    },
    {
      "id": 111642,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "FREYMAN THOMAS C",
      "reporting_owner_cik": "0001239126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "122776"
    },
    {
      "id": 111645,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "MEYER MELODY B",
      "reporting_owner_cik": "0001706126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12523"
    },
    {
      "id": 111647,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RAPP EDWARD J",
      "reporting_owner_cik": "0001171780",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "28584"
    },
    {
      "id": 111653,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "TILTON GLENN F",
      "reporting_owner_cik": "0001194624",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47589"
    },
    {
      "id": 111673,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hart Brett J",
      "reporting_owner_cik": "0001466338",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "15497"
    },
    {
      "id": 111679,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Roberts Rebecca B",
      "reporting_owner_cik": "0001355580",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9753"
    },
    {
      "id": 111689,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SEVERINO MICHAEL",
      "reporting_owner_cik": "0001609447",
      "reporting_owner_position": "Vice Chairman",
      "transaction_date": "2022-05-06",
      "transaction_shares": "74309",
      "transaction_price": "54.44",
      "transaction_type": "M",
      "shares_after_transaction": "226412"
    },
    {
      "id": 111690,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "BURNSIDE WILLIAM H.L.",
      "reporting_owner_cik": "0001563579",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "22983"
    },
    {
      "id": 111692,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "AUSTIN ROXANNE S",
      "reporting_owner_cik": "0001061632",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50705"
    },
    {
      "id": 111697,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "WADDELL FREDERICK H",
      "reporting_owner_cik": "0001223690",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-06",
      "transaction_shares": "1421",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24983"
    }
  ]
}